<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Haematospermia – One‑Page Primary Care Algorithm (NICE CKS)</title>
  <meta name="description" content="A clean, one‑page quick reference algorithm for haematospermia (NICE CKS, last revised March 2022) for rapid decision‑making in primary care." />
  <style>
    :root{
      --bg: #0b1220;          /* page background */
      --panel: #0f172a;       /* card background */
      --muted: #94a3b8;       /* secondary text */
      --text: #e2e8f0;        /* body text */
      --head: #f8fafc;        /* headings */
      --accent: #60a5fa;      /* primary */
      --accent-2: #22d3ee;    /* secondary accent */
      --ok: #22c55e;          /* success */
      --warn: #f59e0b;        /* warning */
      --danger: #ef4444;      /* danger */
      --chip: #1f2937;
      --ring: 0 0 0 2px rgba(96,165,250,.35);
      --radius: 16px;
      --shadow: 0 10px 30px rgba(2,6,23,.35);
      --shadow-soft: 0 6px 16px rgba(2,6,23,.25);
      --gap: clamp(.9rem, 1.2vw, 1.25rem);
    }
    /* Global reset */
    *{box-sizing:border-box}
    html,body{height:100%}
    html{scroll-behavior:smooth}
    body{
      margin:0; font-family: ui-sans-serif, system-ui, -apple-system, Segoe UI, Roboto, Helvetica, Arial, "Apple Color Emoji","Segoe UI Emoji";
      background: radial-gradient(1200px 800px at 10% -10%, #1e293b 0%, transparent 60%),
                  radial-gradient(800px 600px at 110% 10%, #0ea5e9 0%, transparent 40%),
                  linear-gradient(180deg, #0b1220 0%, #0b1220 100%);
      color: var(--text);
    }
    a{color:inherit}
    .container{max-width:1100px;margin:0 auto;padding:24px}

    /* Top bar */
    .toolbar{
      position:sticky; top:0; z-index:10; backdrop-filter:saturate(150%) blur(8px);
      background: linear-gradient(180deg, rgba(15,23,42,.85), rgba(15,23,42,.65));
      border-bottom: 1px solid rgba(148,163,184,.15);
    }
    .toolbar-inner{display:flex; align-items:center; gap:12px; padding:12px 24px}
    .brand{display:flex; align-items:center; gap:12px}
    .brand .logo{width:36px; height:36px; display:grid; place-items:center; border-radius:12px; background:linear-gradient(135deg,var(--accent),var(--accent-2)); box-shadow:var(--shadow-soft)}
    .brand h1{font-size:1.05rem; letter-spacing:.2px; margin:0; color:var(--head)}
    .ghost{margin-left:auto}
    .btn{
      appearance:none; border:0; cursor:pointer; border-radius:12px; padding:10px 14px; font-weight:600;
      background:#0b1324; color:var(--head); box-shadow: var(--shadow-soft);
      border:1px solid rgba(96,165,250,.25);
      display:flex; align-items:center; gap:10px;
    }
    .btn:hover{filter:brightness(1.05)}
    .btn:active{transform:translateY(1px)}
    .btn svg{width:18px;height:18px}

    /* Hero */
    .hero{display:grid; gap:14px; grid-template-columns: 1fr; padding:28px 24px 12px}
    .title{font-size: clamp(1.4rem, 3vw, 1.9rem); margin:0; color:var(--head)}
    .subtitle{margin:0; color:var(--muted)}
    .chips{display:flex; flex-wrap:wrap; gap:8px; margin-top:8px}
    .chip{background:var(--chip); color:#cbd5e1; padding:6px 10px; border-radius:999px; font-size:.85rem; border:1px solid rgba(148,163,184,.2)}
    .chip .dot{display:inline-block;width:8px;height:8px;border-radius:999px;margin-right:8px;background:currentColor}

    /* Layout */
    .grid{display:grid; gap:var(--gap); grid-template-columns: repeat(12, 1fr)}
    .col-8{grid-column: span 8}
    .col-4{grid-column: span 4}
    @media (max-width: 980px){ .col-8, .col-4{grid-column: 1 / -1} }

    /* Card */
    .card{
      background: linear-gradient(180deg, rgba(255,255,255,.02), rgba(255,255,255,.01));
      border: 1px solid rgba(148,163,184,.18);
      border-radius: var(--radius);
      box-shadow: var(--shadow);
      padding: 20px 18px;
    }
    .card h2{margin:0 0 12px; font-size:1.05rem; color:var(--head); display:flex; align-items:center; gap:10px}
    .kicker{font-size:.8rem; letter-spacing:.08em; text-transform:uppercase; color:#a5b4fc}
    .badge{font-size:.75rem; padding:.25rem .5rem; border-radius:8px; border:1px solid rgba(148,163,184,.28); background:#0b1324; color:#c7d2fe}

    /* Lists */
    ul{margin:0; padding-left:1.1rem}
    li{margin:.3rem 0}
    .checklist li{list-style:none; position:relative; padding-left:26px}
    .checklist li::before{content:""; position:absolute; left:0; top:.35rem; width:16px; height:16px; border-radius:6px; background:linear-gradient(135deg, var(--accent) 0%, var(--accent-2) 100%)}
    .hl{color:#e5e7eb}
    .muted{color:var(--muted)}

    /* Sidebar */
    .sidebar{position:sticky; top:72px; display:flex; flex-direction:column; gap:var(--gap)}
    .toc a{display:flex; gap:8px; padding:10px; text-decoration:none; color:#cbd5e1; border-radius:10px; border:1px solid rgba(148,163,184,.18)}
    .toc a:hover{box-shadow: var(--shadow-soft); color:var(--head); border-color: rgba(96,165,250,.35)}

    /* Callouts */
    .callout{display:flex; gap:12px; align-items:flex-start; padding:14px; border-radius:14px; background:rgba(34,197,94,.07); border:1px solid rgba(34,197,94,.3)}
    .callout.warn{background:rgba(245,158,11,.07); border-color:rgba(245,158,11,.35)}
    .callout.danger{background:rgba(239,68,68,.07); border-color:rgba(239,68,68,.35)}
    .callout svg{flex:0 0 18px; margin-top:2px}

    /* Footer */
    footer{margin-top:24px; color:var(--muted); font-size:.9rem}

    /* Print styles (A4, one page) */
    @media print{
      :root{ --bg:#fff; --panel:#fff; --text:#111827; --head:#111827 }
      body{ background:#fff; color:#111827 }
      .toolbar, .sidebar, .print-hide{ display:none !important }
      .container{ max-width: none; padding: 0 }
      .card{ box-shadow:none; border:1px solid #e5e7eb; background:#fff }
      .title{ font-size: 1.25rem }
      .grid{ grid-template-columns: repeat(12,1fr); gap: 10px }
      .col-8{ grid-column: 1 / 9 }
      .col-4{ grid-column: 9 / -1 }
      .chip{ border-color:#cbd5e1; color:#374151 }
      a{ color: #111827; text-decoration: none }
      @page{ size: A4; margin: 10mm }
    }
  </style>
</head>
<body>
  <!-- Toolbar -->
  <div class="toolbar">
    <div class="toolbar-inner container">
      <div class="brand">
        <div class="logo" aria-hidden="true">
          <!-- Inline SVG icon -->
          <svg viewBox="0 0 24 24" fill="none" stroke="white" stroke-width="1.6" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true">
            <path d="M4 12h4l3-9 3 18 3-9h4"/>
          </svg>
        </div>
        <h1>Haematospermia – One‑Page Primary Care Algorithm</h1>
      </div>
      <div class="ghost"></div>
      <button class="btn" onclick="window.print()" title="Print or Save as PDF">
        <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="1.8" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><polyline points="6 9 6 2 18 2 18 9"/><path d="M6 18H4a2 2 0 0 1-2-2v-5a2 2 0 0 1 2-2h16a2 2 0 0 1 2 2v5a2 2 0 0 1-2 2h-2"/><rect x="6" y="14" width="12" height="8" rx="2"/></svg>
        Print / PDF
      </button>
    </div>
  </div>

  <header class="hero container">
    <h2 class="title">Rapid reference for consultations (Adults & ≥12y males)</h2>
    <p class="subtitle">Condensed from NICE CKS (last revised March 2022). Built for fast memory and decision support in primary care.</p>
    <div class="chips">
      <span class="chip"><span class="dot" style="background:var(--accent)"></span>Quick‑scan layout</span>
      <span class="chip"><span class="dot" style="background:var(--ok)"></span>Print‑friendly A4</span>
      <span class="chip"><span class="dot" style="background:var(--warn)"></span>Flags 2WW criteria</span>
      <span class="chip"><span class="dot" style="background:var(--accent-2)"></span>Flow‑by‑sections</span>
    </div>
  </header>

  <main class="container grid" id="top">
    <!-- Main content -->
    <section class="col-8" aria-label="Algorithm content">
      <article id="assessment" class="card">
        <h2>
          <span class="badge">Step 1</span>
          Initial Assessment
        </h2>
        <div class="kicker">Aim: stratify risk & look for red flags</div>
        <ul class="checklist" style="margin-top:10px">
          <li><span class="hl"><strong>Age</strong> → <em>&lt;40y</em> usually benign/infective; <em>≥40y</em> ↑ risk of malignancy.</span></li>
          <li><strong>History</strong>: duration & frequency; colour (bright red vs brown); associated symptoms:
            <ul>
              <li>Dysuria, frequency, urgency, pelvic/perineal pain → consider UTI/prostatitis.</li>
              <li><strong>Painless haematuria</strong> → possible urological malignancy.</li>
              <li>Urethral discharge → STI risk.</li>
              <li>Urinary hesitancy/frequency/dribbling → BPH/prostate CA risk.</li>
              <li>Unilateral testicular swelling / change → testicular tumour.</li>
            </ul>
          </li>
          <li>Recent urological procedure? (biopsy, cystoscopy, vasectomy, radiotherapy)</li>
          <li>PMH/meds: HTN, bleeding disorder, anticoagulants/antiplatelets; FHx prostate CA; sexual & travel history (TB/schisto risk).</li>
          <li><strong>Exam</strong>: BP, temperature; abdomen & nodes; external genitalia; testes/scrotum; <em>consider</em> DRE (size, nodules, tenderness); look for bruising/petechiae.</li>
        </ul>
      </article>

      <article id="investigations" class="card">
        <h2>
          <span class="badge">Step 2</span>
          First‑Line Investigations
        </h2>
        <ul class="checklist" style="margin-top:10px">
          <li><strong>Urinalysis & culture</strong> – <em>all patients</em>.</li>
          <li><strong>PSA</strong> – all men <em>≥40y</em>; consider in younger if FHx/risk or suspicious DRE.</li>
          <li><strong>Targeted tests (as indicated)</strong>:
            <ul>
              <li>FBC, coag screen, renal & LFTs.</li>
              <li>STI screen (GUM clinic if risk) – enables Dx + contact tracing.</li>
              <li>Scrotal ultrasound if swelling/discomfort.</li>
              <li>Semen M/C/S if TB or schistosomiasis suspected.</li>
            </ul>
          </li>
        </ul>
      </article>

      <article id="management" class="card">
        <h2>
          <span class="badge">Step 3</span>
          Management in Primary Care
        </h2>
        <ul class="checklist" style="margin-top:10px">
          <li><strong>Single episode, &lt;40y, no cause</strong> → reassure; safety‑net if persistent/recurrent.</li>
          <li><strong>UTI suspected</strong> → treat per culture & local guidance.</li>
          <li><strong>STI suspected</strong> → refer to GUM clinic for Dx & partner notification.</li>
          <li><strong>Hypertension</strong> → treat per guideline.</li>
          <li><strong>Prostatitis</strong> (acute/chronic) → manage per CKS; review response.</li>
          <li><strong>Post‑procedure</strong> (e.g., prostate biopsy) → reassure: typically resolves in 3–4 weeks.</li>
        </ul>
      </article>

      <article id="referral" class="card">
        <h2>
          <span class="badge">Step 4</span>
          Referral Criteria
        </h2>
        <div class="callout danger" style="margin:10px 0 14px">
          <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="1.8" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><path d="M10.29 3.86L1.82 18a2 2 0 0 0 1.71 3h16.94a2 2 0 0 0 1.71-3L13.71 3.86a2 2 0 0 0-3.42 0z"/><line x1="12" y1="9" x2="12" y2="13"/><line x1="12" y1="17" x2="12.01" y2="17"/></svg>
          <div>
            <strong>Suspected cancer (2‑week‑wait):</strong> ↑PSA or abnormal DRE; clinical suspicion of testicular cancer; painless haematuria or other urological CA features.
          </div>
        </div>
        <div class="callout warn" style="margin:0 0 12px">
          <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="1.8" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><circle cx="12" cy="12" r="10"/><line x1="12" y1="16" x2="12" y2="12"/><line x1="12" y1="8" x2="12.01" y2="8"/></svg>
          <div>
            <strong>Urology (routine/urgent):</strong> all men ≥40y with unexplained haematospermia; any age with persistent/recurrent episodes; ongoing symptoms despite treatment; features suggesting cysts/calculi of prostate/seminal vesicles.
          </div>
        </div>
        <ul class="checklist">
          <li><strong>Other referrals</strong>:
            <ul>
              <li>Haematology if lymphoma/leukaemia suspected.</li>
              <li>Infectious diseases if TB/schistosomiasis suspected.</li>
            </ul>
          </li>
        </ul>
      </article>

      <article id="reassurance" class="card">
        <h2>
          <span class="badge">Step 5</span>
          Key Reassurance Points
        </h2>
        <div class="callout" style="margin:10px 0 0">
          <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="1.8" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><path d="M9 11l3 3L22 4"/><path d="M21 12v7a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V5a2 2 0 0 1 2-2h11"/></svg>
          <div>
            Most cases are benign & self‑limiting; typically no impact on fertility (exception: untreated STIs). Provide safety‑netting advice.
          </div>
        </div>
      </article>
    </section>

    <!-- Sidebar -->
    <aside class="col-4 sidebar" aria-label="Quick links and meta">
      <nav class="card toc" aria-label="On this page">
        <h2 style="margin:0 0 8px">On this page</h2>
        <a href="#assessment">1. Initial Assessment</a>
        <a href="#investigations">2. First‑Line Investigations</a>
        <a href="#management">3. Primary Care Management</a>
        <a href="#referral">4. Referral Criteria</a>
        <a href="#reassurance">5. Reassurance</a>
        <a href="#top" class="print-hide">Back to top ↑</a>
      </nav>

      <section class="card" aria-label="At‑a‑glance">
        <h2>At‑a‑glance</h2>
        <ul class="checklist">
          <li><strong>&lt;40y</strong>: benign/infective most likely.</li>
          <li><strong>≥40y</strong>: PSA for all; consider DRE; lower threshold for referral.</li>
          <li><strong>Always</strong>: urinalysis + MSU.</li>
          <li><strong>GUM</strong> for STI risk (Dx + contact tracing).</li>
          <li><strong>2WW</strong> for prostate/testicular cancer suspicion or painless haematuria.</li>
        </ul>
      </section>

      <section class="card" aria-label="Meta">
        <h2 style="display:flex;align-items:center;gap:8px">Source & Notes</h2>
        <p class="muted" style="margin:.5rem 0 0">Condensed from NICE CKS: Haematospermia (last revised March 2022). For primary care use in the UK.</p>
        <p class="muted" style="margin:.5rem 0 0">This sheet is a decision aide and does not replace clinical judgement or local pathways.</p>
      </section>
    </aside>
  </main>

  <footer class="container" role="contentinfo">
    Built for speed: one page, keyboard accessible, and print‑ready. © Your Clinic.
  </footer>
</body>
</html>